These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 2206036)

  • 1. Expanded clinical evaluation of lovastatin (EXCEL) study: design and patient characteristics of a double-blind, placebo-controlled study in patients with moderate hypercholesterolemia.
    Bradford RH; Shear CL; Chremos AN; Dujovne C; Franklin FA; Hesney M; Higgins J; Langendörfer A; Pool JL; Schnaper H
    Am J Cardiol; 1990 Sep; 66(8):44B-55B. PubMed ID: 2206036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expanded Clinical Evaluation of Lovastatin (EXCEL) study results. I. Efficacy in modifying plasma lipoproteins and adverse event profile in 8245 patients with moderate hypercholesterolemia.
    Bradford RH; Shear CL; Chremos AN; Dujovne C; Downton M; Franklin FA; Gould AL; Hesney M; Higgins J; Hurley DP
    Arch Intern Med; 1991 Jan; 151(1):43-9. PubMed ID: 1985608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expanded clinical evaluation of lovastatin (EXCEL) study results: III. Efficacy in modifying lipoproteins and implications for managing patients with moderate hypercholesterolemia.
    Bradford RH; Shear CL; Chremos AN; Franklin FA; Nash DT; Hurley DP; Dujovne CA; Pool JL; Schnaper H; Hesney M
    Am J Med; 1991 Jul; 91(1B):18S-24S. PubMed ID: 1867232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.
    Downs JR; Clearfield M; Weis S; Whitney E; Shapiro DR; Beere PA; Langendorfer A; Stein EA; Kruyer W; Gotto AM
    JAMA; 1998 May; 279(20):1615-22. PubMed ID: 9613910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison between lovastatin and gemfibrozil in the treatment of primary hypercholesterolemia.
    D'Agostino RB; Kannel WB; Stepanians MN; D'Agostino LC
    Am J Cardiol; 1992 Jan; 69(1):28-34. PubMed ID: 1729864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and tolerability of lovastatin in 3390 women with moderate hypercholesterolemia.
    Bradford RH; Downton M; Chremos AN; Langendörfer A; Stinnett S; Nash DT; Mantell G; Shear CL
    Ann Intern Med; 1993 Jun; 118(11):850-5. PubMed ID: 8480959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expanded Clinical Evaluation of Lovastatin (EXCEL) study results. Effect of patient characteristics on lovastatin-induced changes in plasma concentrations of lipids and lipoproteins.
    Shear CL; Franklin FA; Stinnett S; Hurley DP; Bradford RH; Chremos AN; Nash DT; Langendorfer A
    Circulation; 1992 Apr; 85(4):1293-303. PubMed ID: 1555273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expanded Clinical Evaluation of Lovastatin (EXCEL) study results: two-year efficacy and safety follow-up.
    Bradford RH; Shear CL; Chremos AN; Dujovne CA; Franklin FA; Grillo RB; Higgins J; Langendorfer A; Nash DT; Pool JL
    Am J Cardiol; 1994 Oct; 74(7):667-73. PubMed ID: 7942524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicenter, randomized, double-blind clinical trial comparing the low-density lipoprotein cholesterol-lowering ability of lovastatin 10, 20, and 40 mg/d with fluvastatin 20 and 40 mg/d.
    Davidson MH; Palmisano J; Wilson H; Liss C; Dicklin MR
    Clin Ther; 2003 Nov; 25(11):2738-53. PubMed ID: 14693301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and tolerability of lovastatin in 459 African-Americans with hypercholesterolemia.
    Prisant LM; Downton M; Watkins LO; Schnaper H; Bradford RH; Chremos AN; Langendörfer A
    Am J Cardiol; 1996 Aug; 78(4):420-4. PubMed ID: 8752186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy of intensive dietary therapy alone or combined with lovastatin in outpatients with hypercholesterolemia.
    Hunninghake DB; Stein EA; Dujovne CA; Harris WS; Feldman EB; Miller VT; Tobert JA; Laskarzewski PM; Quiter E; Held J
    N Engl J Med; 1993 Apr; 328(17):1213-9. PubMed ID: 8464431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicenter comparison of lovastatin and probucol for treatment of severe primary hypercholesterolemia. The Lovastatin Study Group IV.
    Am J Cardiol; 1990 Sep; 66(8):22B-30B. PubMed ID: 2206033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of LDL cholesterol in patients with primary hypercholesterolemia by SCH 48461: results of a multicenter dose-ranging study.
    Dujovne CA; Bays H; Davidson MH; Knopp R; Hunninghake DB; Stein EA; Goldberg AC; Jones P; Lipka LJ; Cuffie-Jackson C
    J Clin Pharmacol; 2001 Jan; 41(1):70-8. PubMed ID: 11144997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of once-daily extended-release lovastatin as compared to immediate-release lovastatin in patients with hypercholesterolemia.
    Lukacsko P; Walters EJ; Cullen EI; Niecestro R; Friedhoff LT
    Curr Med Res Opin; 2004 Jan; 20(1):13-8. PubMed ID: 14741066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A softgel dietary supplement containing esterified plant sterols and stanols improves the blood lipid profile of adults with primary hypercholesterolemia: a randomized, double-blind, placebo-controlled replication study.
    McKenney JM; Jenks BH; Shneyvas E; Brooks JR; Shenoy SF; Cook CM; Maki KC
    J Acad Nutr Diet; 2014 Feb; 114(2):244-249. PubMed ID: 24287284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypercholesterolemia in postmenopausal women. Metabolic defects and response to low-dose lovastatin.
    Arca M; Vega GL; Grundy SM
    JAMA; 1994 Feb; 271(6):453-9. PubMed ID: 8295321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of gemfibrozil and lovastatin in patients with high low-density lipoprotein and low high-density lipoprotein cholesterol levels.
    McKenney JM; Barnett MD; Wright JT; Proctor JP
    Arch Intern Med; 1992 Sep; 152(9):1781-7. PubMed ID: 1520045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, double-blind comparison of cerivastatin and lovastatin for treatment of primary hypercholesterolemia.
    Yu WC; Chen CH; Tsao HM; Ding YA
    Zhonghua Yi Xue Za Zhi (Taipei); 2002 Jun; 65(6):260-7. PubMed ID: 12201566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The comparative treatment with lovastatin and bezafibrate of primary hypercholesterolemia. A randomized and double-blind trial].
    Sánchez Domínguez J; Rodríguez Padial L; Navarro A; Barcina C; Fernández E; Rivera G; Cuesta L; Lázaro-Carrasco E
    Rev Esp Cardiol; 1991 Apr; 44(4):251-7. PubMed ID: 2068368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design & rationale of the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS).
    Downs JR; Beere PA; Whitney E; Clearfield M; Weis S; Rochen J; Stein EA; Shapiro DR; Langendorfer A; Gotto AM
    Am J Cardiol; 1997 Aug; 80(3):287-93. PubMed ID: 9264420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.